BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30145943)

  • 21. Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.
    Siva S; Kirby K; Caine H; Pham D; Kron T; Te Marvelde L; Whalley D; Stevens MJ; Foroudi F; MacManus M; Ball D; Eade T
    Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):353-61. PubMed ID: 25698068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Esophageal Cancer: Results and Prognostic Factors.
    Yamamoto T; Niibe Y; Matsumoto Y; Dekura Y; Oh RJ; Yamashita H; Kakuhara H; Aoki M; Jingu K
    Anticancer Res; 2020 Apr; 40(4):2065-2072. PubMed ID: 32234898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Histology, Dose, and Indication Matter.
    Helou J; Thibault I; Poon I; Chiang A; Jain S; Soliman H; Erler D; Yeung L; Cheung P
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):419-427. PubMed ID: 28463162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of extra-cranial stereotactic body radiotherapy for metastatic colorectal cancer: Dose and site of metastases matter.
    Thompson R; Cheung P; Chu W; Myrehaug S; Poon I; Sahgal A; Soliman H; Tseng CL; Wong S; Ung Y; Beatriz Kinupe Abrahão A; Erler D; Zhang L; Ko YJ; Chung HT
    Radiother Oncol; 2020 Jan; 142():236-245. PubMed ID: 31543287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotactic radiotherapy for pulmonary oligometastases: a systematic review.
    Siva S; MacManus M; Ball D
    J Thorac Oncol; 2010 Jul; 5(7):1091-9. PubMed ID: 20479693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer.
    Shultz DB; Filippi AR; Thariat J; Mornex F; Loo BW; Ricardi U
    J Thorac Oncol; 2014 Oct; 9(10):1426-33. PubMed ID: 25170641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotactic Body Radiotherapy for Management of Pulmonary Oligometastases in Stage IV Colorectal Cancer: A Perspective.
    Fu MX; Carvalho C; Milan-Chhatrisha B; Gadi N
    Clin Colorectal Cancer; 2023 Dec; 22(4):402-410. PubMed ID: 37748936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive factors for survival of oligometastatic colorectal cancer treated with Stereotactic body radiation therapy.
    Franzese C; Comito T; Toska E; Tozzi A; Clerici E; De Rose F; Franceschini D; Navarria P; Reggiori G; Tomatis S; Scorsetti M
    Radiother Oncol; 2019 Apr; 133():220-226. PubMed ID: 30414754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases.
    Yamashita H; Niibe Y; Yamamoto T; Katsui K; Jingu K; Kanazawa S; Terahara A; Nakagawa K
    Jpn J Clin Oncol; 2016 Jul; 46(7):687-91. PubMed ID: 27162324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases.
    Klement RJ; Abbasi-Senger N; Adebahr S; Alheid H; Allgaeuer M; Becker G; Blanck O; Boda-Heggemann J; Brunner T; Duma M; Eble MJ; Ernst I; Gerum S; Habermehl D; Hass P; Henkenberens C; Hildebrandt G; Imhoff D; Kahl H; Klass ND; Krempien R; Lewitzki V; Lohaus F; Ostheimer C; Papachristofilou A; Petersen C; Rieber J; Schneider T; Schrade E; Semrau R; Wachter S; Wittig A; Guckenberger M; Andratschke N
    BMC Cancer; 2019 Feb; 19(1):173. PubMed ID: 30808323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies.
    Zaorsky NG; Lehrer EJ; Kothari G; Louie AV; Siva S
    Eur Urol Oncol; 2019 Sep; 2(5):515-523. PubMed ID: 31302061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
    Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
    BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy.
    Milano MT; Katz AW; Schell MC; Philip A; Okunieff P
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1516-22. PubMed ID: 18495378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
    Agolli L; Bracci S; Nicosia L; Valeriani M; De Sanctis V; Osti MF
    Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy.
    Nicosia L; Cuccia F; Mazzola R; Ricchetti F; Figlia V; Giaj-Levra N; Rigo M; Tomasini D; Pasinetti N; Corradini S; Ruggieri R; Alongi F
    Strahlenther Onkol; 2020 Sep; 196(9):813-820. PubMed ID: 32399637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotactic body radiotherapy for bone metastases in patients with colorectal cancer.
    Ito K; Yamaguchi T; Ogawa H; Nakajima Y; Karasawa K
    Jpn J Clin Oncol; 2020 Dec; 50(12):1442-1446. PubMed ID: 32719860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic Body Radiotherapy Results for Pulmonary Oligometastases: A Two-Institution Collaborative Investigation.
    Niibe Y; Yamashita H; Sekiguchi K; Takahashi W; Shiraishi K; Okuma K; Terahara A; Kawamori J; Nakagawa K
    Anticancer Res; 2015 Sep; 35(9):4903-8. PubMed ID: 26254386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary Oligometastases Treated by Stereotactic Body Radiation Therapy: A Nationwide Survey of 1,378 Patients.
    Niibe Y; Yamamoto T; Onishi H; Yamashita H; Katsui K; Matsumoto Y; Oh RJ; Aoki M; Shintani T; Yamada K; Kobayashi M; Ozaki M; Manabe Y; Yahara K; Nishikawa A; Kakuhara H; Yamamoto K; Inoue T; Takada YU; Nagata K; Suzuki O; Terahara A; Jingu K
    Anticancer Res; 2020 Jan; 40(1):393-399. PubMed ID: 31892592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic body radiotherapy for oligometastases.
    Tree AC; Khoo VS; Eeles RA; Ahmed M; Dearnaley DP; Hawkins MA; Huddart RA; Nutting CM; Ostler PJ; van As NJ
    Lancet Oncol; 2013 Jan; 14(1):e28-37. PubMed ID: 23276369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of WBRT alone, SRS alone, and their combination in the treatment of one or more brain metastases: Review and meta-analysis.
    Khan M; Lin J; Liao G; Li R; Wang B; Xie G; Zheng J; Yuan Y
    Tumour Biol; 2017 Jul; 39(7):1010428317702903. PubMed ID: 28675121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.